Category page
Research companies in Europe — biotech directory
European biotech research is anchored by university-affiliated institutes, translational centers that bridge academia and industry, and standalone non-profit research organizations. Anchors include the German Cancer Research Center (DKFZ Heidelberg), Max Delbrück Center (Berlin), Karolinska Institutet (Stockholm), Vilnius University Life Sciences Center (VU LSC), University of Tartu, Helmholtz Centers, plus the Estonian Genome Project. Most operate as non-profit or quasi-public bodies funded by public research grants and industry partnerships.
Where does this category cluster most clearly?
Research is currently most visible through Lithuania (6), Germany (5), Estonia (2), and Latvia (2). Top cities: Vilnius, Lithuania (3), Berlin, Germany (2), Heidelberg, Germany (2), and Riga, Latvia (2). Most legible records: Klaipeda University Health Research and Innovation Science Centre, LSMU Kaunas Clinics Biobank (Human Biological Resources Centre), Stem Cell Research Center (SCRC), and TissUse.
Which standards and public evidence are already visible?
GLP (6) and FDA-Inspected (1). Latest review: 24 April 2026. Review cycle: April 2026.
Why this category matters
This page brings companies and infrastructure records into one practical category view so users can compare markets and cities more quickly.
Related market brief
A plain reading of the 2026 EU biotech regulatory package — pharmaceutical reform, the European Health Data Space, the AI Act, and the upcoming EU Biotech Act — and what biotech, pharma, and CDMO companies should do about it.
Open related briefBy country
Research by country
Jump into a country-specific page filtered to this category only.
Explore more
Other categories
Full list
Research records
18 category records currently match the active filter.
Current review cycle
Klaipeda University Health Research and Innovation Science Centre
KlaipedaLithuaniaResearch
Klaipeda University research centre conducting biomedical and public-health research under contract with Lithuanian and foreign partners, publishing peer-reviewed outputs and organizing international conferences.
- Lead
- Birute StrukcinskieneChief Researcher and Professor of Public Health
- Scale
- University research service delivery
Current review cycle
LSMU Kaunas Clinics Biobank (Human Biological Resources Centre)
KaunasLithuaniaResearch
Lithuanian University of Health Sciences (LSMU) biobank at Kaunas Clinics operating as one of four national BioBank repositories for solid tissue, liquid tissue, live tissue, and health information database samples.
- Lead
- Dalia PangonyteProfessor and BioBank Lead, LSMU
- Scale
- National biobanking operations
Current review cycle
Stem Cell Research Center (SCRC)
VilniusLithuaniaResearch
Vilnius Stem Cell Research Center managing the Lithuanian Stem Cell and Regenerative Medicine Cluster, with a disclosed 27 million EUR investment plan at Northtown and a 3D bioprinting research axis under the Northway group.
- Lead
- Vladas Algirdas BumelisFounder and Chairman of the Board, Northway group
- Scale
- Research center and cluster operations
Current review cycle
TissUse
BerlinGermanyResearch
Berlin organ-on-chip company developing multi-organ microphysiological systems for drug development, toxicology, and advanced human tissue models.
- Lead
- Uwe MarxChief Executive Officer
- Scale
- Research-platform operations
Current review cycle
Statens Serum Institut
CopenhagenDenmarkResearch
Copenhagen national public-health institute operating infectious-disease surveillance, reference diagnostics, preparedness functions, and laboratory infrastructure central to Denmark's life-sciences and health-security system.
- Lead
- Henrik UllumPresident and CEO
- Scale
- National-scale public-health and diagnostic infrastructure
Current review cycle
Inobiostar
KlaipėdaLithuaniaResearch
Klaipėda deep-tech spinout developing blue-biotech and environmental-biotechnology solutions, including oil-spill treatment, aerogel materials, and marine innovation projects.
- Lead
- Tatjana PaulauskienėDirector
- Scale
- Early-stage applied biotechnology and innovation platform
Current review cycle
TFTAK
TallinnEstoniaResearch
Tallinn food-and-biotechnology research organization combining bioprocess optimization, microbiome research, pilot-plant work, and contract innovation services for industrial partners.
- Lead
- Martin Lall, MScChief Executive Officer
- Scale
- Applied contract research and pilot-scale biotechnology platform
Current review cycle
BIOR
RigaLatviaResearch
Riga national laboratory and research institute combining analytical testing, medical laboratory services, reference-laboratory functions, and public-science infrastructure across Latvia.
- Lead
- Dr Olga ValcinaDirector
- Scale
- National research and reference-laboratory network
Current review cycle
AstraZeneca Gothenburg
GothenburgSwedenResearch
Gothenburg strategic science-centre anchor integrating discovery biology, translational research, and global biopharma development programs.
- Lead
- Pascal SoriotChief Executive Officer
- Scale
- Global biopharmaceutical research and development
Current review cycle
Center for Physical Sciences and Technology
VilniusLithuaniaResearch
Vilnius national research institute spanning materials science, photonics, chemistry, and applied life-science instrumentation.
- Lead
- Assoc. Prof. Dr. Rimantas RamanauskasGeneral Director
- Scale
- Large interdisciplinary research institute
Current review cycle
Vilnius University Life Sciences Center
VilniusLithuaniaResearch
Vilnius University flagship life-science campus integrating biochemistry, molecular biology, biotechnology, and training infrastructure.
- Lead
- Assoc. Prof. Dr. Eugenijus ButkusHead of Center
- Scale
- University life-science flagship campus
Current review cycle
German Cancer Research Center
HeidelbergGermanyResearch
Heidelberg cancer-research flagship integrating oncologic discovery, prevention, translational programmes, and national research infrastructure.
- Lead
- Prof. Dr. Michael BaumannChairman and Scientific Director
- Scale
- Large national oncology-research centre
Current review cycle
EMBL Heidelberg
HeidelbergGermanyResearch
Heidelberg European molecular-biology site linking structural biology, genomics, data, and international training infrastructure into the wider cluster.
- Lead
- Jan KorbelInterim Head of Site, EMBL Heidelberg
- Scale
- European molecular-biology flagship site
Current review cycle
Max Delbruck Center Berlin-Buch
BerlinGermanyResearch
Berlin-Buch biomedical research centre combining disease-biology programmes, technology platforms, and translational partnerships across the German capital region.
- Lead
- Prof. Dr. Maike SanderChair of the Board and Scientific Director
- Scale
- Large biomedical research centre
Current review cycle
Evotec
HamburgGermanyResearch
Hamburg discovery and development platform spanning integrated R&D, translational biology, and industrialized biotech partnerships.
- Lead
- Dr. Christian WojczewskiChief Executive Officer and Chair of the Management Board
- Scale
- Global research platform
Current review cycle
Selvita
KrakowPolandResearch
Integrated drug discovery and development CRO platform with major research operations in Krakow and a multi-site delivery footprint across Poland. The verified March 2026 record captures current executive leadership and a live preclinical-to-development operating profile.
- Lead
- Bogusław SieczkowskiChief Executive Officer
- Scale
- Multi-site research services platform
Current review cycle
Estonian Genome Center
TartuEstoniaResearch
University of Tartu genomics and biobank node supporting population-scale sequencing, genotyping, and precision-medicine research built on the Estonian Biobank.
- Lead
- Prof. Elin OrgHead of Estonian Genome Centre
- Scale
- Population Scale
Current review cycle
Institute of Organic Synthesis
RigaLatviaResearch
Riga medicinal-chemistry and drug-discovery institute combining synthetic chemistry, pharmacology, process research, and translational infrastructure inside Latvia's strongest chemistry campus.
- Lead
- Dace KārkleDirector
- Scale
- Discovery / Pilot
FAQ
Frequently asked questions
- What is the difference between research and discovery in this directory?
- Research = institutional capacity (universities, public institutes, translational centers, science parks). Drug Discovery = company-owned IP and pipelines. A research institute generates fundamental knowledge and may translate it into spin-outs; a discovery company commercializes specific candidates.
- Which European institutions lead biotech research?
- Germany hosts the deepest non-profit infrastructure (DKFZ, MDC, Helmholtz Munich, MPI). Switzerland: ETH Zurich, EPFL, Roche Innovation Center. Sweden: Karolinska Institutet, SciLifeLab. Lithuania: Vilnius University Life Sciences Center. Estonia: University of Tartu, Estonian Genome Project. Each institution interfaces with the surrounding industry via translational programs.
- How are research organizations verified in this directory?
- Every profile is hand-reviewed: institutional identity confirmed by primary source, physical site address sourced from official disclosures, research focus and program scope backed by published documentation, and a registry note explaining current research focus and industry-relevance.
Next step
Read the category, then move into cities and countries.
Use city pages for local concentration, country pages for market context, and the methodology page when you want to understand how records are reviewed.